Trulieve Cannabis (TCNNF) FCF Margin (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly FCF Margin of 17.8% in Q1 2026, down 23.39% quarter-over-quarter from 23.24% in Q4 2025, and up 159.0% on a YoY basis from 6.87% in Q1 2025.
Trulieve Cannabis (TCNNF) FCF Margin (2020 - 2026) Analysis & Trends
Trulieve Cannabis' FCF Margin history runs 7 years deep, the most recent figure standing at 17.8% for Q1 2026.
- In Q1 2026, FCF Margin rose 159.0% year-over-year to 17.8%; the TTM figure through Mar 2026 stood at 23.23% (up 716.0% YoY), while the FY2025 annual figure was 22.78%, up 35.0% from the prior year.
- FCF Margin was 17.8% for Q1 2026 at Trulieve Cannabis, down from 23.24% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 60.81% in Q4 2022 to a low of 46.55% in Q2 2022.
- Historically, FCF Margin has averaged 16.06% across 5 years, with a median of 17.8% in 2026.
- The sharpest annual moves came in 2022 and 2023: FCF Margin sank 4128 bps in 2022, then surged 5277 bps in 2023.
- A 5-year view of FCF Margin shows it stood at 60.81% in 2022, then decreased by 26 bps to 44.81% in 2023, then dropped by 22 bps to 34.95% in 2024, then sank by 34 bps to 23.24% in 2025, then fell by 23 bps to 17.8% in 2026.
- The last three FCF Margin figures came in at 17.8% (Q1 2026), 23.24% (Q4 2025), and 22.76% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -429.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 13.24% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 32.62% |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 17.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.80% |
| Dec 31, 2025 | 23.24% |
| Sep 30, 2025 | 22.76% |
| Jun 30, 2025 | 28.83% |
| Mar 31, 2025 | 16.21% |
| Dec 31, 2024 | 34.95% |
| Sep 30, 2024 | -2.74% |
| Jun 30, 2024 | 14.84% |
| Mar 31, 2024 | 41.55% |
| Dec 31, 2023 | 44.81% |
| Sep 30, 2023 | 32.73% |
| Jun 30, 2023 | -5.01% |
| Mar 31, 2023 | -4.67% |
| Dec 31, 2022 | 60.81% |
| Sep 30, 2022 | -20.04% |
| Jun 30, 2022 | -46.55% |
| Mar 31, 2022 | 13.51% |
| Dec 31, 2021 | 41.82% |
| Sep 30, 2021 | -72.77% |
| Jun 30, 2021 | -5.27% |